Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
InMed Pharmaceuticals Inc. See All Filings	D	2022-12-05 19:25:32 UTC
Amount To Be Raised $6,000,177 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001728328 Filed Document 0001213900-22-077730 Exclusions or Exemptions 506b Accepted Date 2022-12-05 19:25:32 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business BRITISH COLUMBIA, CANADA Revenue or Assets Decline to Disclose Type of Security Equity
InMed Pharmaceuticals Inc. See All Filings	D	2022-06-08 14:26:12 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC and ROTH Capital Partners, LLC CIK Number 0001728328 Filed Document 0001213900-22-031723 Exclusions or Exemptions 506b Accepted Date 2022-06-08 14:26:12 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business BRITISH COLUMBIA, CANADA Revenue or Assets Decline to Disclose Type of Security Equity
InMed Pharmaceuticals Inc. See All Filings	D	2021-10-28 11:29:54 UTC
Amount To Be Raised $4,305,000 Associated Brokers / Dealers N/A CIK Number 0001728328 Filed Document 0001213900-21-054992 Exclusions or Exemptions 506b Accepted Date 2021-10-28 11:29:54 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business BRITISH COLUMBIA, CANADA Revenue or Assets Decline to Disclose Type of Security Equity
InMed Pharmaceuticals Inc. See All Filings	D	2021-07-19 06:13:42 UTC
Amount To Be Raised $12,000,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC and ROTH Capital Partners, LLC CIK Number 0001728328 Filed Document 0001213900-21-037354 Exclusions or Exemptions 506b Accepted Date 2021-07-19 06:13:42 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business BRITISH COLUMBIA, CANADA Revenue or Assets Decline to Disclose Type of Security Equity
InMed Pharmaceuticals Inc. See All Filings	D	2018-01-17 16:59:51 UTC
Amount To Be Raised $4,551,022 Associated Brokers / Dealers Canaccord Genuity Corp. CIK Number 0001728328 Filed Document 0001728328-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-01-17 16:59:51 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business BRITISH COLUMBIA, CANADA Revenue or Assets $No Revenues Type of Security Equity